News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Lannett Company, Inc. (LCI) And HEC Pharm Announce U.S.-China Drug Distribution/CMO Plans



5/13/2014 8:14:45 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

by Richard Daverman, PhD

May 12, 2014 -- Lannett Company, a US-based generic drug company, set up bilateral distribution and contract manufacturing agreements with HEC Pharm Group (HEC) of Shenzhen, China. Lannett will become the exclusive US distributor of zidovudine for HEC’s US subsidiary, Sunshine Lake. The two companies plan to add products to the agreement as they are approved, and Lannett will use Sunshine Lake’s contract manufacturing and distribution services to lower costs and market its generic drugs in China. More details....

Stock Symbol: (NYSE: LCI)

Help employers find you! Check out all the jobs and post your resume.

Read at ChinaBio Today


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES